☆ 4.4 Letter

Lenalidomide maintenance after allogeneic HSCT seems to trigger acute graft-versus-host disease in patients with high-risk myelodysplastic syndromes or acute myeloid leukemia and del(5q): results of the LENAMAINT trial

HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2012)

Get Full Text
Add to Collection

Journal

HAEMATOLOGICA-THE HEMATOLOGY JOURNAL
Volume 97, Issue 9, Pages E34-E35

Publisher

FERRATA STORTI FOUNDATION
DOI: 10.3324/haematol.2012.067629

Keywords

myelodysplastic syndromes; acute myeloid leukemia; allogeneic stem cell transplantation; lenalidomide; maintenance

Categories

Hematology

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.4
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available
Webinars Posters Questions Hubs Funding Journals Papers Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.